Knowledge, attitudes and practices of pharmacists concerning prescription drug abuse

Journal of Psychoactive Drugs

Volumn 38, Issue 3, 2006, Pages 229-232

  Lafferty, Lynn ^a   Hunter, Tracy S ^b   Marsh, Wallace A ^a  

^a University of Oklahoma College of Pharmacy ^*  (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF PHARMACY   (United States)

Author keywords

Addiction; Education; Pharmacist; Prescription drug abuse

Indexed keywords

CAREER; CONTINUING EDUCATION; DEMOGRAPHY; DRUG ABUSE; HUMAN; NEUROBIOLOGY; PAIN; PHARMACIST ATTITUDE; PRESCRIPTION; PROFESSIONAL PRACTICE; QUESTIONNAIRE; REVIEW;

EID: 33751064531     PISSN: 02791072     EISSN: 21599777     Source Type: Journal    
DOI: 10.1080/02791072.2006.10399848     Document Type: Article

References (16)

1. Addiction ScienceNetwork. 2000 A Primer on DrugAddiction. Available at: http://www.addictionscience.net/ASNprimer.htmwww.addictionscience.net/ASNprimer.
2. American Society of Helath System Pharmacists (ASHP). 2003. ASHP Statement on the Pharmacist's Role in Substance Abuse Prevention, Education andAssistance. Available at www.ashp.org/bestpractices/medtherapy/Specific_St_Substance.pdf
3. Baldwin, J.N.; Dole, E.J.; Levine, P.J.; Light, K.E.; Murawski, M.M.; Stock, C.; Tommasello, A.C. & Waterhouse G.A.W. 1994. Survey of pharmacy substance abuse course content. American Journal of Pharmaceutical Education 58: 47S-52S.
4. Bressler, L.R.; Geraci, M.C. & Schatz, B.S. 1991. Misconceptions and inadequate pain management in cancer patients. Annals of Pharmacotherapy (2) 5: 1225-30.
5. Center on Addiction and Substance Abuse (CASA). 2005. Under the Counter: The Diversion andAbuse of Controlled Prescription Drugs in the U.S. New York: CASA.
6. Cobaugh, D.J. 2003. Pharmacists' role in preventing andtreating substance abuse. Why are we doing so little? American Journal of Health-System Pharmacy 60 (19): 1947.
7. Dole, E.J. & Tommasello, A. 2002. Recommendations for implementing effective substance abuse education in pharmacy practice. Substance Abuse 23 (Suppl.): 263-71.
8. Krick, S.E.; Lindley C.M. & Bennett, M. 1994. Pharmacy-perceived barriers to cancer pain control: Result of the North Carolina cancer pain initiative pharmacist survey. Annals of Pharmacotherapy 28: 857-62.
9. Leshner, A.I. 1999. Science-based views of drug addiction and its treatment. Journal oftheAmerican Medical Association 282: 131-416.
10. McRae, A.L. & Brady, K.T. 2005. Opioid receptor agonists: Methadone, levomethadyl, and buprenorphine. In: B.J. Sadock & VA. Sadock (Eds) Kaplan & Sadock's Comprehensive Textbook of Psychiatry. Hagerstown: Lippincott Williams & Wilkins.
11. National Association of Boards of Pharmacy. 2005. National Association of Boards of Pharmacy Survey. Available at napb.net
12. Paice, C.; Tou, C. & Shott, S. 1998. Barriers to cancer pain relief: Fear of tolerance and addiction. Journal of Pain and Symptom Management 16: 1-9.
13. PR Newswire. 2005. New Gallup Poll Names Nurses "Most Ethical" Profession. Available at: http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=/www/story/12-05-2005/004228059&EDATE
14. Schwartz, M. 1998. You're number one as a health advisor. U.S. Pharmacist 23 (7). Available at: www.uspharmacist.com/oldformat.asp?url=newlook/files/view/temp.htm
15. Simoni-Wastila, L. & Stickler, G. 2004. Risk factors associated with problem use of prescription drugs. American Journal of Public Health 94 (2): 266-8.
16. Substance Abuse and Mental Health Services Administration (SAMHA). 2005. Overview of Findings from the 20004 National Survey on Drug Use and Health. Office of Applied Studies, NSDUH Series H-27, DHHS Publication No. SMA 05-4061. Rockville, MD: SAMHSA.